UC Irvine scientists have found a new way to sort stem cells that should be quicker, easier and more cost-effective than current methods. The technique could in the future expedite therapies for people with conditions ranging from brain and spinal cord damage to Alzheimer’s and Parkinson’s diseases.

A brain chemical that makes us sleepy also appears to play a central role in the success of deep brain stimulation to ease symptoms in patients with Parkinson’s disease and other brain disorders. The surprising finding is outlined in a paper published online Dec. 23 in Nature Medicine.

Does the consumption of green tea, widely touted to have beneficial effects on health, also protect brain cells" Authors of a new study being published in the December 15th issue of Biological Psychiatry share new data that indicates this may be the case.

The person you’re speaking with may be looking at you, but are they really paying attention" Or has the person covertly shifted their attention, without moving their eyes" Dr. Brian Corneil, of the Centre for Brain and Mind at The University of Western Ontario in London, Canada has found a way of actually measuring covert attention.

The person you’re speaking with may be looking at you, but are they really paying attention" Or has the person covertly shifted their attention, without moving their eyes" Dr. Brian Corneil, of the Centre for Brain and Mind at The University of Western Ontario in London, Canada has found a way of actually measuring covert attention.

Omega-3 fatty acids protect the brain against Parkinson’s disease, according to a study by Université Laval researchers published in the online edition of the FASEB Journal, the journal of the Federation of American Societies for Experimental Biology.

In an advance that may speed progress toward new diagnostic tests for Alzheimer’s disease (AD) and Parkinson’s disease (AD), scientists in New York are reporting development of the first direct method for measuring a key enzyme implicated in both of those chronic brain disorders. The study is scheduled for the Nov. 21 issue of ACS’ Journal of the American Chemical Society, a weekly publication.

Researchers at the Saint Louis University School of Medicine have discovered the key brain chemical that causes Parkinson's disease - a breakthrough finding that could pave the way for new, far more effective therapies to treat one of the most common and debilitating neurological disorders.

For those who suffer with the debilitating symptoms of Parkinson's disease, Deep Brain Stimulation offers relief from the tremors and rigidity that can't be controlled by medicine.

The Parkinson’s Institute and Clinical Center today announced research showing that intermittent nicotine treatment reduces medication-induced dyskinesias by as much as 50 percent in models of Parkinson’s disease. Lead by senior research scientist, Maryka Quik, Ph.D., the research will be published in an upcoming issue of the Annals of Neurology.

In a finding that may lead to potential new treatments for diseases such as Alzheimer's and Parkinson's, researchers at the Picower Institute for Learning and Memory at MIT report an unexpected role in the brain for a well-known protein.

Relatives of patients with Parkinson’s disease may have an increased risk of developing dementia or cognitive impairment, according to a report in the October issue of Archives of Neurology, one of the JAMA/Archives journals.